Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | C3h11orf96 | Rat | 15-acetyldeoxynivalenol | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | 15-acetyldeoxynivalenol results in increased expression of C11ORF96 mRNA | CTD | PMID:23792671 | C3h11orf96 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of C3H11ORF96 mRNA | CTD | PMID:22298810|PMID:34747641 | C3h11orf96 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of C3H11ORF96 mRNA | CTD | PMID:32109520 | C3h11orf96 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of C11ORF96 mRNA | CTD | PMID:21632981 | C3h11orf96 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | C3h11orf96 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Gm13889 (Mus musculus) | 6480464 | Fenretinide results in increased expression of C11ORF96 mRNA | CTD | PMID:28973697 | C3h11orf96 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Decitabine affects the expression of C11ORF96 mRNA | CTD | PMID:23300844 | C3h11orf96 | Rat | aflatoxin B1 | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of C11ORF96 mRNA | CTD | PMID:21632981|PMID:21641981 | C3h11orf96 | Rat | all-trans-retinoic acid | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of C11ORF96 mRNA | CTD | PMID:21934132|PMID:23724009 | C3h11orf96 | Rat | antirheumatic drug | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of C11ORF96 mRNA | CTD | PMID:24449571 | C3h11orf96 | Rat | Archazolid B | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | archazolid B results in increased expression of C11ORF96 mRNA | CTD | PMID:25218289 | C3h11orf96 | Rat | azathioprine | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Azathioprine results in increased expression of C11ORF96 mRNA | CTD | PMID:22623647 | C3h11orf96 | Rat | belinostat | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | belinostat results in increased expression of C11ORF96 mRNA | CTD | PMID:26272509 | C3h11orf96 | Rat | belinostat | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | benzo[a]pyrene | increases methylation | ISO | C11orf96 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of C11ORF96 promoter | CTD | PMID:27901495 | C3h11orf96 | Rat | beta-lapachone | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of C11ORF96 mRNA | CTD | PMID:38218311 | C3h11orf96 | Rat | beta-naphthoflavone | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of C11ORF96 mRNA | CTD | PMID:32858204 | C3h11orf96 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of C11ORF96 mRNA | CTD | PMID:25181051 | C3h11orf96 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | C3h11orf96 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of C3H11ORF96 gene | CTD | PMID:28505145 | C3h11orf96 | Rat | bisphenol A | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of C11ORF96 mRNA | CTD | PMID:27685785 | C3h11orf96 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | C3h11orf96 | Rat | butanal | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of C11ORF96 mRNA | CTD | PMID:26079696 | C3h11orf96 | Rat | cadmium atom | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Cadmium results in increased expression of C11ORF96 mRNA | CTD | PMID:24376830 | C3h11orf96 | Rat | cadmium dichloride | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of C11ORF96 mRNA | CTD | PMID:38174414|PMID:38568856 | C3h11orf96 | Rat | cannabidiol | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of C11ORF96 mRNA | CTD | PMID:27918106 | C3h11orf96 | Rat | carbamazepine | affects expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of C11ORF96 mRNA | CTD | PMID:25979313 | C3h11orf96 | Rat | chromium(6+) | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression more ... | CTD | PMID:38479592 | C3h11orf96 | Rat | cisplatin | affects expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Cisplatin affects the expression of C11ORF96 mRNA | CTD | PMID:23300844 | C3h11orf96 | Rat | cisplatin | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of C11ORF96 mRNA | CTD | PMID:27392435 | C3h11orf96 | Rat | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of C3H11ORF96 mRNA | CTD | PMID:27899881 | C3h11orf96 | Rat | copper atom | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of C11ORF96 mRNA; [NSC 689534 binds more ... | CTD | PMID:20971185|PMID:24690739 | C3h11orf96 | Rat | copper(0) | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of C11ORF96 mRNA; [NSC 689534 binds more ... | CTD | PMID:20971185|PMID:24690739 | C3h11orf96 | Rat | crocidolite asbestos | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in increased expression of C11ORF96 mRNA | CTD | PMID:25757056 | C3h11orf96 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of C3H11ORF96 mRNA | CTD | PMID:26577399 | C3h11orf96 | Rat | cyclosporin A | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of C11ORF96 mRNA | CTD | PMID:27989131 | C3h11orf96 | Rat | cyclosporin A | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of C11ORF96 mRNA | CTD | PMID:25562108 | C3h11orf96 | Rat | cylindrospermopsin | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of C11ORF96 mRNA | CTD | PMID:24921660 | C3h11orf96 | Rat | dinophysistoxin 1 | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | dinophysistoxin 1 results in increased expression of C11ORF96 mRNA | CTD | PMID:28939011 | C3h11orf96 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression more ... | CTD | PMID:33729688 | C3h11orf96 | Rat | disulfiram | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of C11ORF96 mRNA | CTD | PMID:24690739 | C3h11orf96 | Rat | dorsomorphin | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | entinostat | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | entinostat | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | entinostat results in increased expression of C11ORF96 mRNA | CTD | PMID:26272509 | C3h11orf96 | Rat | FR900359 | increases phosphorylation | ISO | C11orf96 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of C11ORF96 protein | CTD | PMID:37730182 | C3h11orf96 | Rat | fulvestrant | increases methylation | ISO | C11orf96 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of C11ORF96 gene | CTD | PMID:31601247 | C3h11orf96 | Rat | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of C3H11ORF96 gene | CTD | PMID:22079235 | C3h11orf96 | Rat | hexadecanoic acid | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Palmitic Acid results in increased expression of C11ORF96 mRNA | CTD | PMID:32347412 | C3h11orf96 | Rat | iron dichloride | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | ferrous chloride results in increased expression of C11ORF96 mRNA | CTD | PMID:35984750 | C3h11orf96 | Rat | lead(0) | affects expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Lead affects the expression of C11ORF96 mRNA | CTD | PMID:28903495 | C3h11orf96 | Rat | malathion | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Malathion results in increased expression of C11ORF96 mRNA | CTD | PMID:37047231 | C3h11orf96 | Rat | mercury dibromide | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of C11ORF96 mRNA | CTD | PMID:26272509 | C3h11orf96 | Rat | mercury dibromide | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of C3H11ORF96 mRNA | CTD | PMID:19564919 | C3h11orf96 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of C11ORF96 mRNA | CTD | PMID:24810058 | C3h11orf96 | Rat | okadaic acid | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of C11ORF96 mRNA | CTD | PMID:38832940 | C3h11orf96 | Rat | panobinostat | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | panobinostat | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | panobinostat results in increased expression of C11ORF96 mRNA | CTD | PMID:26272509 | C3h11orf96 | Rat | pentanal | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | pentanal results in increased expression of C11ORF96 mRNA | CTD | PMID:26079696 | C3h11orf96 | Rat | phenylmercury acetate | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of C11ORF96 mRNA | CTD | PMID:26272509 | C3h11orf96 | Rat | phenylmercury acetate | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of C3H11ORF96 mRNA | CTD | PMID:12832660 | C3h11orf96 | Rat | propanal | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of C11ORF96 mRNA | CTD | PMID:26079696 | C3h11orf96 | Rat | quercetin | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Quercetin results in increased expression of C11ORF96 mRNA | CTD | PMID:21632981 | C3h11orf96 | Rat | rotenone | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Rotenone results in increased expression of C11ORF96 mRNA | CTD | PMID:29955902 | C3h11orf96 | Rat | SB 431542 | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | silicon dioxide | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of C11ORF96 mRNA | CTD | PMID:23806026|PMID:25895662 | C3h11orf96 | Rat | silver atom | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Silver results in increased expression of C11ORF96 mRNA | CTD | PMID:26014281 | C3h11orf96 | Rat | silver(0) | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Silver results in increased expression of C11ORF96 mRNA | CTD | PMID:26014281 | C3h11orf96 | Rat | sodium arsenite | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of C11ORF96 mRNA | CTD | PMID:38568856 | C3h11orf96 | Rat | sunitinib | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of C11ORF96 mRNA | CTD | PMID:31533062 | C3h11orf96 | Rat | thapsigargin | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of C11ORF96 mRNA | CTD | PMID:29453283 | C3h11orf96 | Rat | thiram | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Thiram results in increased expression of C11ORF96 mRNA | CTD | PMID:38568856 | C3h11orf96 | Rat | torcetrapib | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of C11ORF96 mRNA | CTD | PMID:23228038 | C3h11orf96 | Rat | trichostatin A | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of C11ORF96 mRNA | CTD | PMID:26272509 | C3h11orf96 | Rat | trichostatin A | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | triclosan | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of C11ORF96 mRNA | CTD | PMID:30510588 | C3h11orf96 | Rat | tunicamycin | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of C11ORF96 mRNA | CTD | PMID:29453283 | C3h11orf96 | Rat | urethane | decreases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Urethane results in decreased expression of C11ORF96 mRNA | CTD | PMID:28818685 | C3h11orf96 | Rat | urethane | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Urethane results in increased expression of C11ORF96 mRNA | CTD | PMID:28818685 | C3h11orf96 | Rat | valproic acid | affects expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of C11ORF96 mRNA | CTD | PMID:25979313 | C3h11orf96 | Rat | valproic acid | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | valproic acid | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of C11ORF96 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799 | C3h11orf96 | Rat | vorinostat | increases expression | ISO | C11orf96 (Homo sapiens) | 6480464 | vorinostat results in increased expression of C11ORF96 mRNA | CTD | PMID:26272509 | C3h11orf96 | Rat | vorinostat | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | C3h11orf96 | Rat | zinc atom | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of C11ORF96 mRNA | CTD | PMID:18593933 | C3h11orf96 | Rat | zinc(0) | multiple interactions | ISO | C11orf96 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of C11ORF96 mRNA | CTD | PMID:18593933 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















